Proceedings: Factors determining gallstone dissolution in patients treated with chenodeoxycholic acid (CDCA).
D002635:Chenodeoxycholic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D002769:Cholelithiasis / Q000188:drug therapy*; D005704:Gallbladder / Q000503:physiopathology; D006801:Humans; D013997:Time Factors
D002635:Chenodeoxycholic Acid